WASHINGTON, Oct. 13, 2009 (GLOBE NEWSWIRE) -- Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Avocent Corp. ("Avocent" or the "Company") (Nasdaq:AVCT) arising from the Company's announcement of its intent to merge with Emerson Electric Co. ("Emerson").
Under the terms of the proposed merger agreement, Avocent shareholders will receive $25 in cash for each share of Avocent common stock they own for a total transaction value of $1.2 billion. One analyst has given a $27 per share target price for the Company's stock.
The investigation is focused on the potential unfairness of the consideration to Avocent shareholders and the process by which the Avocent Board of Directors is addressing the transaction. The Avocent Board of Directors has agreed to a $35 million termination fee and/or reimbursement of transaction expenses to Emerson up to $7.5 million.
If you are interested in discussing your rights as an Avocent shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at contact@finkelsteinthompson.com.
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.